Although undoubtedly important in the care of the patient with epilepsy, advances in neurologic diagnosis and treatment tended to obscure the behavioral manifestations of epilepsy until Gibbs drew attention to the high incidence of behavioral disorders in patients with temporal lobe epilepsy.
The Jessner Peel is generally considered a medium level peel containing 14% of each acid (Salicylic, Lactic, and Resorcinol.) The depth of this peel is determined by the number of layers applied during application and the tolerance level of the skin it is applied to.
Background. Jessner lymphocytic infiltrate of the skin (LIS) is a benign yet chronic, T-cell infiltrative disease, first described in 1953 by Jessner and Kanof. The condition has remained poorly understood, and indeed, the very existence of such a condition has been questioned.